Sogroya® (somapacitan-beco) injection is a once-weekly growth hormone injection used to treat children aged 2.5 years or older and adults with growth hormone deficiency (GHD). Read important safety & prescribing info.

2023年7月18日 · Sogroya is a prescription medicine that is used to treat people with growth hormone deficiency. Sogroya is given by injection under the skin (subcutaneous) to replace growth hormones that are normally produced in the body. What is Sogroya used to treat? Sogroya is used to treat adults with growth hormone deficiency.

Sogroya ® is the first and only once-weekly growth hormone (GH) treatment for both children and adults with growth hormone deficiency (GHD). In a 1-year (52-week) study of 200 children who had never been treated for growth hormone deficiency (GHD), Sogroya ® was compared with a daily GH treatment (somatropin). a.

Sogroya ® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg is indicated for the: treatment of pediatric patients aged 2.5 years and older who have growth failure due to inadequate secretion of endogenous growth hormone (GH)

Use our tool to learn about selected attributes of the Sogroya® pen injector and a range of other daily and weekly growth hormone therapy devices. This chart is not intended to be a comparison of efficacy or safety of any of these products. This is neither a comprehensive description of each product nor a complete list of available therapies.

FDA approved Sogroya (somapacitan) on August 28 for adults with growth hormone deficiency. Sogroya is the first human growth hormone (hGH) therapy that adult patients only take once a week;...

SOGROYA is a human growth hormone analog indicated for: Pediatric Patients: Treatment of pediatric patients aged 2.5 years and older who have growth failure due to inadequate secretion of endogenous growth hormone (GH) (1). Adults: Replacement of endogenous growth hormone in adults with growth hormone deficiency (1).

Sogroya ® is indicated for pediatric patients aged 2.5 years and older with growth failure due to inadequate secretion of endogenous growth hormone (GH), and for replacement of endogenous GH in adults with growth hormone deficiency (GHD). Please see full indications. See the science behind Sogroya ®.

2025年2月20日 · SOGROYA is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body. SOGROYA is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone. Do not use SOGROYA if:

Sogroya (somapacitan-beco) is commonly used for children who are not growing as expected (growth failure) due to their bodies not making enough growth hormone. This is also called growth hormone...